Evaxion A (EVAX) Tax Provisions (2020 - 2026)
Evaxion A's (EVAX) quarterly Tax Provisions came in at $216000.0 in Q1 2026, up 12.5% YoY from $192000.0 in Q1 2025, and down 15.29% on a QoQ basis from $255000.0 in Q4 2025.
Evaxion A (EVAX) Tax Provisions (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of Tax Provisions data on file, last reported at $216000.0 in Q1 2026.
- Quarterly Tax Provisions rose 12.5% year-over-year to $216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $931000.0 (up 22.18% YoY) and the FY2025 annual result came in at $908000.0, up 15.23% from the prior year.
- Tax Provisions eased to $216000.0 in Q1 2026, from $255000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $275000.0 in Q4 2024 to a low of $96000.0 in Q3 2024.
- A 5-year average of $204294.1 and a median of $195000.0 in 2025 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions slumped 88.34% — and 2025, when it jumped 176.04%.
- Tracing EVAX's Tax Provisions over 5 years: stood at $173000.0 in 2022, then rose by 2.31% to $177000.0 in 2023, then soared by 55.37% to $275000.0 in 2024, then declined by 7.27% to $255000.0 in 2025, then retreated by 15.29% to $216000.0 in 2026.
- The last three Tax Provisions figures came in at $216000.0 (Q1 2026), $255000.0 (Q4 2025), and $265000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | 216,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Sep 30, 2023 | 194,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 177,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 1.08 Mn |